Location History:
- Beijing, CN (2010 - 2014)
- Haidian District, CN (2020)
Company Filing History:
Years Active: 2010-2020
Title: Yongling Wan: Innovator in Pharmaceutical Advancements
Introduction
Yongling Wan is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic agents for various medical conditions. With a total of 4 patents to his name, his work is recognized for its potential impact on healthcare.
Latest Patents
Among his latest patents, Yongling Wan has developed a thrombin-like enzyme aimed at reducing the side effects of anticancer drugs. This invention provides a novel agent that can mitigate adverse reactions associated with cancer treatments. Additionally, he has created a therapeutic agent for lower urinary tract diseases, including conditions such as cystitis and benign prostatic hyperplasia. This agent is designed to improve symptoms related to these often-refractory diseases.
Career Highlights
Yongling Wan is currently associated with Tobishi Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to addressing complex medical challenges through scientific research and development.
Collaborations
Yongling has collaborated with notable colleagues, including Hirobumi Senga and Lishui Chang. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in their field.
Conclusion
Yongling Wan's contributions to pharmaceutical innovations highlight his dedication to improving patient outcomes through scientific advancements. His patents reflect a commitment to addressing significant health issues, making him a valuable figure in the realm of medical research.